Wearable Sensing is an early-stage MedTech company focused on non-invasive brain monitoring. With over $28M in non-dilutive funding, we have pioneered, patented, and manufactured the highest fidelity dry electrode EEG monitoring headsets that have already generated over $13M in revenue from sales in the research and neurofeedback markets.
We are raising a $15M series A to accelerate our growth in the emerging wearable neurotech market, which is a growing segment of the $383B mental health market. For our beachhead, we will leverage our avid adoption in the $1.1B neurofeedback market, which is a non-pharmacological therapy that has been demonstrated to treat various mental disorders, including anxiety, depression, and ADHD.
We plan to scale up a next-generation EEG+VR neurofeedback subscription service for clinicians that will uniquely enable them to grow their businesses by offering hybrid in-clinic and at-home remote treatments. This subscription business model could later be replicated for numerous other nascent neurotech applications.